OBJECTIVE: In dyslipidemic states, platelets become hyperreactive, secreting molecules that promote atherosclerosis. We have shown that the semaphorin family member, sema4D (CD100), is expressed on the surface of platelets and proposed that its role includes promoting thrombus growth by binding to nearby platelets and endothelial cells, both of which express sema4D receptors. Here we tested the hypothesis that deleting sema4D will attenuate the adverse consequences of dyslipidemia on platelets and the vessel wall. METHODS AND RESULTS: Platelet function and atherosclerotic lesion formation were measured in LDLR(-/-) and sema4D(-/-)LDLR(-/-) mice after 6 months on a high-fat diet. All of the mice developed the dyslipidemia expected on this diet in the absence of functional LDL receptors. However, when compared to LDLR(-/-) mice, sema4D(-/-) LDLR(-/-) mice had reduced lipid deposition in the descending aorta, a 6-fold decrease in the frequency of arterial occlusion and a reduction to near wild-type levels in the accumulation of platelets after injury. These differences were retained ex vivo, with a marked decrease in platelet accumulation on collagen under flow and in platelet aggregation. CONCLUSIONS: These results show that loss of sema4D expression reduces the platelet hyperactivity otherwise found in dyslipidemia, and confers protection against the development of atherosclerosis.
OBJECTIVE: In dyslipidemic states, platelets become hyperreactive, secreting molecules that promote atherosclerosis. We have shown that the semaphorin family member, sema4D (CD100), is expressed on the surface of platelets and proposed that its role includes promoting thrombus growth by binding to nearby platelets and endothelial cells, both of which express sema4D receptors. Here we tested the hypothesis that deleting sema4D will attenuate the adverse consequences of dyslipidemia on platelets and the vessel wall. METHODS AND RESULTS: Platelet function and atherosclerotic lesion formation were measured in LDLR(-/-) and sema4D(-/-)LDLR(-/-) mice after 6 months on a high-fat diet. All of the mice developed the dyslipidemia expected on this diet in the absence of functional LDL receptors. However, when compared to LDLR(-/-) mice, sema4D(-/-) LDLR(-/-) mice had reduced lipid deposition in the descending aorta, a 6-fold decrease in the frequency of arterial occlusion and a reduction to near wild-type levels in the accumulation of platelets after injury. These differences were retained ex vivo, with a marked decrease in platelet accumulation on collagen under flow and in platelet aggregation. CONCLUSIONS: These results show that loss of sema4D expression reduces the platelet hyperactivity otherwise found in dyslipidemia, and confers protection against the development of atherosclerosis.
Authors: Gregor Theilmeier; Carine Michiels; Erik Spaepen; Ingrid Vreys; Désiré Collen; Jos Vermylen; Marc F Hoylaerts Journal: Blood Date: 2002-06-15 Impact factor: 22.113
Authors: A J Cayatte; Y Du; J Oliver-Krasinski; G Lavielle; T J Verbeuren; R A Cohen Journal: Arterioscler Thromb Vasc Biol Date: 2000-07 Impact factor: 8.311
Authors: David G Grenache; Trey Coleman; Clay F Semenkovich; Samuel A Santoro; Mary M Zutter Journal: Arterioscler Thromb Vasc Biol Date: 2003-09-25 Impact factor: 8.311
Authors: Arnon Afek; Evgeny Kogan; Sofia Maysel-Auslender; Adi Mor; Ehud Regev; Ardon Rubinstein; Gad Keren; Jacob George Journal: Microvasc Res Date: 2009-01-31 Impact factor: 3.514
Authors: Karen P Fong; Colin Barry; Anh N Tran; Elizabeth A Traxler; Kenneth M Wannemacher; Hsin-Yao Tang; Kaye D Speicher; Ian A Blair; David W Speicher; Tilo Grosser; Lawrence F Brass Journal: Blood Date: 2010-10-20 Impact factor: 22.113
Authors: Amarylis Wanschel; Tara Seibert; Bernd Hewing; Bhama Ramkhelawon; Tathagat D Ray; Janine M van Gils; Katey J Rayner; Jonathan E Feig; Edward R O'Brien; Edward A Fisher; Kathryn J Moore Journal: Arterioscler Thromb Vasc Biol Date: 2013-02-21 Impact factor: 8.311
Authors: Kathryn J Moore; Simon Koplev; Edward A Fisher; Ira Tabas; Johan L M Björkegren; Amanda C Doran; Jason C Kovacic Journal: J Am Coll Cardiol Date: 2018-10-30 Impact factor: 24.094